# Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy

> **NCT00296049** · NA · WITHDRAWN · sponsor: **Wake Forest University Health Sciences**

## Conditions studied

- Infection
- Neutropenia
- Unspecified Adult Solid Tumor, Protocol Specific
- Unspecified Childhood Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** daptomycin
- **DRUG:** vancomycin

## Key facts

- **NCT ID:** NCT00296049
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-07
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2018-08-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00296049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00296049, "Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00296049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*